Kombinationsbehandling med thyroxin og trijodthyronin til patienter med hypotyreose

Translated title of the contribution: Combination therapy of thyroxine and triiodothyronine in hypothyroid patients

Birte Nygaard, Michael E Røder, Jesper Karmisholt, Jette Kolding Kristensen

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Decreased quality of life is described more often in hypothyroid patients, who are treated with a synthetic form of thyroxine (L-T4), than in euthyroid controls. A combination of L-T4 and a synthetic form of triiodothyronine (L-T3) has been suggested; however, previous meta-analyses on unselected patients did not find any effect. Recent studies demonstrate, that the overall hypothalamic-pituitary-thyroid-tissue homeostasis could be more complex than previously suggested. Polymorphisms in deiodinase and thyroid hormone transporter genes could theoretically explain, why a minor subgroup of hypothyroid patients seem to have an effect of L-T4/L-T3 combination therapy.

Translated title of the contributionCombination therapy of thyroxine and triiodothyronine in hypothyroid patients
Original languageDanish
Article numberV04170328
JournalUgeskrift for Laeger
Volume180
Issue number19
Pages (from-to)2-5
Number of pages4
ISSN0041-5782
Publication statusPublished - 2018

Fingerprint

Dive into the research topics of 'Combination therapy of thyroxine and triiodothyronine in hypothyroid patients'. Together they form a unique fingerprint.

Cite this